Pfizer has raised its full-year profit guidance as its cost-cutting efforts build steam and US President Donald Trump pushes drugmakers to slash their prices.
随着成本削减措施逐步见效，以及美国总统唐纳德•特朗普(Donald Trump)敦促制药商降低药价，辉瑞(Pfizer)上调了全年利润指引。
您已阅读9%（228字），剩余91%（2176字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。